Effects of nonsteroid anti-inflammatory agents and some dicoumarol derivatives on platelet aggregation, fibrinolysis and stabilization of cell membrane in vitro.
D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects*; D002462:Cell Membrane / Q000187:drug effects; D002738:Chloroquine / Q000494:pharmacology; D003374:Coumarins / Q000494:pharmacology; D003864:Depression, Chemical; D001728:Dicumarol / Q000494:pharmacology*; D004912:Erythrocytes / Q000187:drug effects; D005342:Fibrinolysis / Q000187:drug effects*; D005439:Flufenamic Acid / Q000494:pharmacology; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D007038:Hypotonic Solutions; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D007249:Inflammation / Q000188:drug therapy; D008528:Mefenamic Acid / Q000494:pharmacology; D010113:Oxyphenbutazone / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D010666:Phenylpropionates / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011720:Pyrazoles / Q000494:pharmacology; D011955:Receptors, Drug; D013329:Structure-Activity Relationship
D000893:Anti-Inflammatory Agents; D003374:Coumarins; D007038:Hypotonic Solutions; D010666:Phenylpropionates; D011720:Pyrazoles; D011955:Receptors, Drug; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D001728:Dicumarol; D002738:Chloroquine; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D001241:Aspirin; D007213:Indomethacin